Equal Opportunity Supplemented by Fair Innings: Equity and Efficiency in Allocating Deceased Donor Kidneys

被引:32
作者
Ross, L. F. [1 ,2 ,7 ]
Parker, W. [3 ]
Veatch, R. M. [4 ]
Gentry, S. E. [5 ,6 ]
Thistlethwaite, J. R., Jr. [7 ]
机构
[1] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA
[2] Univ Chicago, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA
[3] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
[4] Georgetown Univ, Kennedy Inst Eth, Washington, DC 20057 USA
[5] USN Acad, Dept Math, Annapolis, MD 21402 USA
[6] Johns Hopkins Univ, Dept Surg, Baltimore, MD USA
[7] Univ Chicago, Dept Surg, Sect Transplantat, Chicago, IL 60637 USA
关键词
Age-matching; efficiency; equal opportunity; equity; ethics; fair innings; kidney transplantation; lifespan equity; organ allocation; public policy; utility; RENAL-TRANSPLANTATION; RACIAL DISPARITIES; RISK;
D O I
10.1111/j.1600-6143.2012.04141.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
For 7 years, the Kidney Transplantation Committee of the United Network for Organ Sharing/Organ Procurement Transplantation Network has attempted to revise the kidney allocation algorithm for adults (=18 years) in end-stage renal disease awaiting deceased donor kidney transplants. Changes to the kidney allocation system must conform to the 1984 National Organ Transplant Act (NOTA) which clearly states that allocation must take into account both efficiency (graft and person survival) and equity (fair distribution). In this article, we evaluate three allocation models: the current system, age-matching and a two-step model that we call Equal Opportunity Supplemented by Fair Innings (EOFI). We discuss the different conceptions of efficiency and equity employed by each model and evaluate whether EOFI could actually achieve the NOTA criteria of balancing equity and efficiency given current conditions of growing scarcity and donor-candidate age mismatch.
引用
收藏
页码:2115 / 2124
页数:10
相关论文
共 33 条
[31]  
Veatch RobertM., 2000, TRANSPLANTATION ETHI
[32]  
Williams A, 1997, HEALTH ECON, V6, P117, DOI 10.1002/(SICI)1099-1050(199703)6:2<117::AID-HEC256>3.0.CO
[33]  
2-B